Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cyclophosphamide
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients
Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.
The risk of varicella zoster virus infection in multiple sclerosis patients treated with fingolimod.
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Shorter washout reduces MS relapse switching off natalizumab
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
The history of the oxazaphosphorine cytostatics.
Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response.
Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord.
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab.
Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.

Pages